N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide (BioDeep_00000181124)
human metabolite blood metabolite
代谢物信息卡片
化学式: C26H26N6O4 (486.2015)
中文名称: MRS1754
谱图信息:
最多检出来源 Homo sapiens(blood) 100%
分子结构信息
SMILES: CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N
InChI: InChI=1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30)
描述信息
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
同义名列表
23 个代谢物同义名
N-(4-Cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide; N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide; N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide; 8-(4-(((4-Cyanophenyl)carbamoylmethyl)oxy)phenyl)-1,3-di(ni-propyl)xanthine; MRS 1754; (4-Cyano-phenyl)-carbamic acid 4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenyl ester; [3H]-MRS1754; [3H]MRS1754; 7E435V2DAH; 8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine; 8-[4-[((4-Cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine hydrate; Acetamide, N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)-; Acetamide, N-(4-cyanophenyl)-2-(4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)-; Acetamide, N-(4-cyanophenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-; Lopac0_000729; N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide; N-(4-Cyano-phenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy]-acetamide(MRS-1754); N-(4-Cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)-acetamide; N-(4-cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)acetamide; N-(4-Cyanophenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamide; N-(4-Cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide; N-(4-cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)phenoxy]acetamide; UNII-7E435V2DAH
数据库引用编号
8 个数据库交叉引用编号
- ChEBI: CHEBI:93269
- PubChem: 6603931
- HMDB: HMDB0254927
- ChEMBL: CHEMBL273807
- chemspider: 5036239
- CAS: 264622-58-4
- medchemexpress: HY-14121
- MeSH: N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide
分类词条
相关代谢途径
Reactome()
BioCyc()
PlantCyc()
代谢反应
个相关的代谢反应过程信息。
Reactome()
BioCyc()
WikiPathways()
Plant Reactome()
INOH()
PlantCyc()
COVID-19 Disease Map()
PathBank()
PharmGKB()
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- Ángelo Torres, Katherin Muñoz, Yessica Nahuelpán, Angelo-Paolo R Saez, Pablo Mendoza, Claudia Jara, Claudio Cappelli, Raibel Suarez, Carlos Oyarzún, Claudia Quezada, Rody San Martín. Intraglomerular Monocyte/Macrophage Infiltration and Macrophage-Myofibroblast Transition during Diabetic Nephropathy Is Regulated by the A2B Adenosine Receptor.
Cells.
2020 04; 9(4):. doi:
10.3390/cells9041051
. [PMID: 32340145] - Shyamsundar Pal China, Subhashis Pal, Sourav Chattopadhyay, Konica Porwal, Monika Mittal, Sabyasachi Sanyal, Naibedya Chattopadhyay. The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor κB ligand in osteoblasts: Negative impact of the drug on peak bone accrual in rats.
Toxicology and applied pharmacology.
2018 06; 348(?):22-31. doi:
10.1016/j.taap.2018.04.006
. [PMID: 29649498] - Leena Patel, Aswin Thaker. The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy.
Journal of pharmacology & pharmacotherapeutics.
2015 Jul; 6(3):147-53. doi:
10.4103/0976-500x.162014
. [PMID: 26311998] - Angel Cárdenas, Camilo Toledo, Carlos Oyarzún, Angélica Sepúlveda, Claudia Quezada, Elena Guillén-Gómez, Montserrat M Díaz-Encarnación, Marçal Pastor-Anglada, Rody San Martín. Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy.
Laboratory investigation; a journal of technical methods and pathology.
2013 Jan; 93(1):135-44. doi:
10.1038/labinvest.2012.143
. [PMID: 23069939] - Ming-Guo Feng, L Gabriel Navar. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.
American journal of physiology. Renal physiology.
2010 Aug; 299(2):F310-5. doi:
10.1152/ajprenal.00149.2010
. [PMID: 20462966] - John A Auchampach, Laura M Kreckler, Tina C Wan, Jason E Maas, Dharini van der Hoeven, Elizabeth Gizewski, Jayashree Narayanan, Garren E Maas. Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.
The Journal of pharmacology and experimental therapeutics.
2009 Apr; 329(1):2-13. doi:
10.1124/jpet.108.148270
. [PMID: 19141710] - Sergey Ryzhov, Rinat Zaynagetdinov, Anna E Goldstein, Sergey V Novitskiy, Michael R Blackburn, Italo Biaggioni, Igor Feoktistov. Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines.
The Journal of pharmacology and experimental therapeutics.
2008 Feb; 324(2):694-700. doi:
10.1124/jpet.107.131540
. [PMID: 17965229] - Daniela C G Bertarelli, Martina Diekmann, Alaa M Hayallah, Dorothee Rüsing, Jamshed Iqbal, Birgit Preiss, Eugen J Verspohl, Christa E Müller. Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies.
Purinergic signalling.
2006 Sep; 2(3):559-71. doi:
10.1007/s11302-006-9012-4
. [PMID: 18404493] - Soon-Ai Kim, Melissa A Marshall, Neli Melman, Hak Sung Kim, Christa E Müller, Joel Linden, Kenneth A Jacobson. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Journal of medicinal chemistry.
2002 May; 45(11):2131-8. doi:
10.1021/jm0104318
. [PMID: 12014951] - X Ji, Y C Kim, D G Ahern, J Linden, K A Jacobson. [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
Biochemical pharmacology.
2001 Mar; 61(6):657-63. doi:
10.1016/s0006-2952(01)00531-7
. [PMID: 11266650] - Y C Kim, X Ji, N Melman, J Linden, K A Jacobson. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Journal of medicinal chemistry.
2000 Mar; 43(6):1165-72. doi:
10.1021/jm990421v
. [PMID: 10737749]